EUVIMEDEUVIMED entdecken
EditorialKommentar

Oral Fosfomycin for Pyelonephritis: Re-examining the Pooled Evidence

Recep Balik iD

Clinical Infectious Diseases · 14.11.2026

DOI: 10.1093/cid/ciag710 ↗

Kurz gefasst

Editorial in der Zeitschrift Clinical Infectious Diseases, online erschienen am 14.11.2026. Verfasst von Recep Balik. Beteiligte Einrichtung: Department of Infectious Diseases and Clinical Microbiology, Haydarpaşa Numune Training and Research Hospital, İstanbul, Türkiye.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Autor:innen und Institutionen

  • Department of Infectious Diseases and Clinical Microbiology, Haydarpaşa Numune Training and Research Hospital, İstanbul, Türkiye.

ORCID-Profile: Recep Balik

Zitieren

APA

Balik, R. (2026). Oral Fosfomycin for Pyelonephritis: Re-examining the Pooled Evidence. Clinical Infectious Diseases. https://doi.org/10.1093/cid/ciag710

Vancouver

Balik R. Oral Fosfomycin for Pyelonephritis: Re-examining the Pooled Evidence. Clinical Infectious Diseases. 2026. doi:10.1093/cid/ciag710

BibTeX
@article{Balik2026,
  author = {Balik, Recep},
  title = {Oral Fosfomycin for Pyelonephritis: Re-examining the Pooled Evidence},
  journal = {Clinical Infectious Diseases},
  year = {2026},
  doi = {10.1093/cid/ciag710}
}
Kostenlos starten →